Abstract
The Protein Kinase C (PKC) activator Bryostatin 1 (B1) influences the CNS by enhancing immune activation, neuronal plasticity, and trophic factor production. Because PKC signaling interacts with other neuromodulatory
pathways, B1’s efficacy likely depends on brain state and neuropathological context. Enhancing neuromodulation may, in turn, potentiate B1’s effects, supporting combined interventions. Motivated by this, we examined the
interplay between B1 and noradrenaline (NE) in regulating inflammation and neuronal maturation in vitro. While B1 alone showed modest activity, it significantly amplified NE’s actions, particularly in stimulating microglial activation
and phagocytosis, while reducing cytokine expression, oxidative stress, and inflammatory markers. B1 also modestly supported neuronal maturation improving neurite outgrowth. Notably, B1 and NE were more effective
in activated than resting microglia, especially in a scratch wound model. Overall, our findings highlight additive and synergistic effects of B1 and NE in inflammatory contexts, supporting combinatorial therapeutic strategies
and brain-state-dependent approaches in neuroimmune modulation.
pathways, B1’s efficacy likely depends on brain state and neuropathological context. Enhancing neuromodulation may, in turn, potentiate B1’s effects, supporting combined interventions. Motivated by this, we examined the
interplay between B1 and noradrenaline (NE) in regulating inflammation and neuronal maturation in vitro. While B1 alone showed modest activity, it significantly amplified NE’s actions, particularly in stimulating microglial activation
and phagocytosis, while reducing cytokine expression, oxidative stress, and inflammatory markers. B1 also modestly supported neuronal maturation improving neurite outgrowth. Notably, B1 and NE were more effective
in activated than resting microglia, especially in a scratch wound model. Overall, our findings highlight additive and synergistic effects of B1 and NE in inflammatory contexts, supporting combinatorial therapeutic strategies
and brain-state-dependent approaches in neuroimmune modulation.
| Originalsprache | Englisch |
|---|---|
| Publikationsstatus | Veröffentlicht - 9 Sept. 2025 |
| Veranstaltung | Austrian Neuroscience Association ANA meeting 2025 - ISTA Institute of Science and Technology Austria, Klosterneuburg, Österreich Dauer: 8 Sept. 2025 → 10 Sept. 2025 https://ana-meeting-2025.ista.ac.at/ |
Konferenz mit wissenschaftlichem Inhalt
| Konferenz mit wissenschaftlichem Inhalt | Austrian Neuroscience Association ANA meeting 2025 |
|---|---|
| Kurztitel | ANA Meeting |
| Land/Gebiet | Österreich |
| Ort | Klosterneuburg |
| Zeitraum | 8/09/25 → 10/09/25 |
| Internetadresse |
Aktivitäten
- 1 Teilnahme an einer Konferenz, einem Workshop
-
Austrian Neuroscience Association ANA meeting 2025
Couillard-Després, S. (Organisator/in), Benedetti, B. (Mitglied Organisationskomitee), Nöbauer, M. (Teilnehmer/in) & Pruonto, G. (Teilnehmer/in)
8 Sept. 2025 → 10 Sept. 2025Aktivität: Teilnahme an oder Organisation einer Veranstaltung › Teilnahme an einer Konferenz, einem Workshop
Dieses zitieren
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver